Mandate

Vinge has advised Svea Bank AB in connection with the issuance of Additional Tier 1 Capital of SEK 300 million

December 20, 2023 Banking and Finance

Vinge has advised Svea Bank AB (the “Company”) in connection with its issuance of SEK 300 million additional tier 1 capital bonds (AT1) with a floating rate interest of 3-month STIBOR + 7.50%.

The issue date is set to 20 December 2023, and the bonds have a perpetual maturity with first permitted redemption date after 5 years. The issuance is in the form of a debt instrument with automatic write-down of its nominal amount if the common equity tier 1 capital ratio of the Company falls below a certain level. The instruments will be listed on Nasdaq Stockholm.

Vinge’s team consisted of Mikael Ståhl, Arvid Weimers and Sofia Haggren.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025